Boris-Lawrie, Kathleen

Dr. Boris-Lawrie

Kathleen Boris-Lawrie, PhD

Executive Director, Life Sciences Network
Active Member, Center for Retrovirus Research, Center for RNA Biology, Comprehensive Cancer Center 

Department of Veterinary Biosciences
The Ohio State University
350 Veterinary Medical Academic Building
1900 Coffey Road
Columbus, Ohio 43210
Ph: (614) 292-1392
Ph: (614) 292-8703 (lab)
Fx: (614) 292-6473
boris-lawrie [dot] 1 [at] osu [dot] edu

Education, research training and experience

  • BS in Microbiology; MA in Microbiology, Southern Illinois Univ, Carbondale, IL; Morey Academic Fellow; Graduate Research Fellow
  • PhD in Molecular Genetics, George Washington Univ, Washington D.C.; Hoffman LaRoche Predoctoral fellow;
  • National Institutes of Health Student Research Training Predoctoral Fellow, Laboratory of Molecular Virology, National Cancer Institute, Bethesda, MD
  • Molecular Virology post-doctoral T32 fellow, McArdle Laboratory for Cancer Research, Univ of Wisconsin Medical School, Madison, WI;
  • Research Biologist I, Drug Discovery Group, Lederle Laboratories, American Cyanamid Company, Pearl River, NY
  • Research Biologist II, Antibiotic Genetics Group, Corporate Molecular Biology, Abbott Laboratories, Abbott Park, IL
  • Assistant Professor, Department of Veterinary Biosciences; Department of Molecular Virology, Immunology & Medical Genetics, Ohio State University, Columbus, OH
  • Associate Professor, Departments of Veterinary Biosciences and Molecular Virology, Immunology & Medical Genetics, Ohio State University, Columbus, OH
  • Professor, Department of Veterinary Biosciences; Department of Molecular Virology, Immunology & Medical Genetics, Ohio State University, Columbus, OH

Research Summary

Our lab team is creative and ambitious. Our thinking is multidisciplinary and hypothesis-based.  Our attitude is collaborative.  In a nutshell, we collect genomic and proteomic data from mammalian cells, and employ genetic, cell biological, biochemical and biophysical strategies to research our hypotheses.  Our purpose is to uncover fundamental concepts governing the biology of cells and viruses in health and disease.  We hope to translate our findings therapeutically to eliminate virally-infected lymphocytes and pre-cancerous cells.

Present collaborators

  • International: Cestmir Altaner, Slovak Academy of Sciences; Alan Cochrane, University of Toronto, Canada
  • National Institutes for Health Structural Biology Center for RNA: Leslie Parent, University of Michigan; Xiao Heng, University of Missouri; Mike Summers, Univ Maryland, Baltimore County; Paul Bienasiaz, Rockefeller University
  • Ohio State University: Jesse Kwiek, Beth Lee, Michael Freitas, College of Medicine; Karin Musier-Forsyth, College of Arts and Sciences; Robert M. Lee, College of Pharmacy

Research Keywords 

Infectious disease; gene expression; etroviruses; post-transcriptional control; translation control; cis-acting RNA elements; RNA binding proteins; RNA helicase; ribonucleoprotein particles (RNPs)